{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:49:41Z","timestamp":1775278181039,"version":"3.50.1"},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.6983-25","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:08:45Z","timestamp":1774908525000},"source":"Crossref","is-referenced-by-count":0,"title":["Mosapride as a Pre-Endoscopy Preparation in a Patient Receiving GLP-1 Receptor Agonist Therapy"],"prefix":"10.2169","author":[{"given":"Kazuki","family":"Inoue","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Morisawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Fumihara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Sako","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Momose","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Furumatsu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Osaka Saiseikai Nakatsu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Camilleri M, Lupianez-Merly C. Effects of GLP-1 and other gut hormone receptors on the gastrointestinal tract and implications in clinical practice. Am J Gastroenterol 119: 1028-1037, 2024.","DOI":"10.14309\/ajg.0000000000002519"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wu F, Smith MR, Mueller AL, et al. Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study. Can J Anaesth 71: 958-966, 2024.","DOI":"10.1007\/s12630-024-02781-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yeo YH, Gaddam S, Ng WH, Huang PC, Ma KS, Rezaie A. Increased risk of aspiration pneumonia associated with endoscopic procedures among patients with glucagon-like peptide 1 receptor agonist use. Gastroenterology 167: 402-404, 2024.","DOI":"10.1053\/j.gastro.2024.03.015"},{"key":"4","unstructured":"4. American Society of Anesthesiologists. Perioperative management of patients on GLP-1 receptor agonists: practice advisory [Internet]. 2023 Available from: https:\/\/www.asahq.org\/"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: an update. Anesthesiology 126: 547-560, 2017.","DOI":"10.1097\/ALN.0000000000001515"},{"key":"6","unstructured":"6. American Gastroenterological Association. AGA clinical practice update on endoscopic procedures in patients using GLP-1 receptor agonists: clinical practice update [Internet]. 2024 Available from: https:\/\/www.gastro.org\/"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Alkabbani W, Suissa K, Gu KD, et al. Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study. BMJ 387: e080340, 2024.","DOI":"10.1136\/bmj-2024-080340"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Singh S, Chandan S, Dahiya DS, et al. Impact of GLP-1 receptor agonists in gastrointestinal endoscopy: an updated review. Journal of Clinical Medicine 13: 5627, 2024.","DOI":"10.3390\/jcm13185627"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hongo M, Harasawa S, Mine T, et al. Large-scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega-Study (JMMS). J Gastroenterol Hepatol 27: 62-68, 2012.","DOI":"10.1111\/j.1440-1746.2011.06949.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Amano T, Ariga H, Kurematsu A, et al. Effect of 5-hydroxytryptamine receptor 4 agonist mosapride on human gastric accommodation. Neurogastroenterol Motil 27: 1303-1309, 2015.","DOI":"10.1111\/nmo.12623"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Asha MZ, Khalil SFH. Pharmacological Approaches to Diabetic Gastroparesis: A systematic review of randomised clinical trials. Sultan Qaboos Univ Med J 19: e400-e410, 2019.","DOI":"10.18295\/squmj.2019.19.04.004"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Quast DR, Schenker N, Menge BA, Nauck MA, Kapitza C, Meier JJ. Effects of lixisenatide versus liraglutide (short- and long-acting GLP-1 receptor agonists) on esophageal and gastric function in patients with type 2 diabetes. Diabetes Care 43: 2137-2145, 2020.","DOI":"10.2337\/dc20-0720"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6983-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:55:32Z","timestamp":1775274932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_6983-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":12,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6983-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"6983-25"}}